Search - tctmd.com

Displaying 121 - 140 of 435

Sort: Relevancy | Date

News Daily News

AI-Enabled Algorithm Succeeds in Identifying Diabetes From ECG Data

Yael L. Maxwell

August 12, 2022

News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Michael O'Riordan

August 11, 2022

News Daily News

Lowering BP Boosts CV Health Irrespective of Diabetes: Meta-analysis

Todd Neale

August 02, 2022

News Daily News

CV Risk Factors, Disease Projected to Explode in Coming Decades

L.A. McKeown

August 01, 2022

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

Shelley Wood

July 25, 2022

News Daily News

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

Yael L. Maxwell

July 22, 2022

News Daily News

CVD, Diabetes Spike in Acute Phase of COVID-19

Todd Neale

July 19, 2022

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Daily News

‘Redlining’ of Neighborhoods Left a Legacy of Poorer CV Health

L.A. McKeown

July 04, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Daily News

Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE

Michael O'Riordan

June 17, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

L.A. McKeown

March 17, 2022

News Daily News

Strength Training Linked to Less Premature Mortality, CVD, and Diabetes

Michael O'Riordan

March 02, 2022

News Daily News

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

L.A. McKeown

March 01, 2022

News Daily News

FDA Approves Empagliflozin for Treatment of HFpEF

Michael O'Riordan

February 24, 2022

News Daily News

Fewer Diabetic Complications Seen When NOACs Given for AF

L.A. McKeown

February 22, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

Poor Prepregnancy Cardiometabolic Health Observed Across the US

Yael L. Maxwell

February 14, 2022

Advertisement

AI-Enabled Algorithm Succeeds in Identifying Diabetes From ECG Data

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Lowering BP Boosts CV Health Irrespective of Diabetes: Meta-analysis

CV Risk Factors, Disease Projected to Explode in Coming Decades

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

CV Risk Factor Control Cuts Post-op Nursing Home Transfer for Black Americans

CVD, Diabetes Spike in Acute Phase of COVID-19

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

‘Redlining’ of Neighborhoods Left a Legacy of Poorer CV Health

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

Too Much Sitting Linked to Bad Outcomes Around the Globe: PURE

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Good News and Bad for High-Intensity Statin Use in ASCVD

Diet Drinks May Help With Weight Loss and Cardiometabolic Control

Strength Training Linked to Less Premature Mortality, CVD, and Diabetes

GRACE Performs Poorly in Ethnic Minorities With NSTEMI, Study Finds

FDA Approves Empagliflozin for Treatment of HFpEF

Fewer Diabetic Complications Seen When NOACs Given for AF

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Poor Prepregnancy Cardiometabolic Health Observed Across the US

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content